Autonomous AI at the point of care significantly increases diabetic retinopathy screening rates among young patients, addressing access gaps in underserved communities and offering a practical solution to improve patient outcomes.

AI chatbots like ChatGPT-4 and Claude AI have demonstrated superior performance to oncologists in delivering accurate, empathetic, and readable responses to patient inquiries about cancer, suggesting a promising adjunct to clinical practice.

The rise of telepsychiatry during the pandemic has increased ADHD diagnoses in adults, yet challenges remain in ensuring thorough evaluations and compliance with evolving prescribing regulations.

Noninvasive neuromodulation devices offer effective headache management options with minimal adverse events, providing both acute and preventive treatment capabilities. Understanding their mechanisms and practical uses is crucial for optimizing patient care.

A study presented at AAPA 2024 shows that AI, particularly a multilayer perceptron model, significantly improves the prediction of in-hospital cardiac arrest in emergency settings compared to the traditional Modified Early Warning Score.

An innovative blood test using artificial intelligence has shown the potential to detect Parkinson’s disease up to seven years before symptoms appear, offering new possibilities for early intervention and treatment.